Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alport syndrome--clinical phenotypes, incidence, and pathology.

Literature DB >> 8801040

Alport syndrome--clinical phenotypes, incidence, and pathology.

M C Gregory¹, D A Terreros, D F Barker, P N Fain, J C Denison, C L Atkin.

Abstract

Mesh：

Year: 1996 PMID： 8801040 DOI： 10.1159/000424804

Source DB: PubMed Journal: Contrib Nephrol ISSN： 0302-5144 Impact factor: 1.580

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Ocular manifestations of Alport syndrome.

Authors: Jian-Min Xu; Shi-Sheng Zhang; Qiong Zhang; Ying-Ming Zhou; Cai-Hong Zhu; Jian Ge; Ling Wang
Journal: Int J Ophthalmol Date: 2010-06-18 Impact factor: 1.779

2. The effect of aldosterone blockade in patients with Alport syndrome.

Authors: Hiroshi Kaito; Kandai Nozu; Kazumoto Iijima; Koichi Nakanishi; Kunihiko Yoshiya; Kyoko Kanda; Rafal Przybyslaw Krol; Norishige Yoshikawa; Masafumi Matsuo
Journal: Pediatr Nephrol Date: 2006-10-13 Impact factor: 3.714

3. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.

Authors: D Cosgrove; K Rodgers; D Meehan; C Miller; K Bovard; A Gilroy; H Gardner; V Kotelianski; P Gotwals; A Amatucci; R Kalluri
Journal: Am J Pathol Date: 2000-11 Impact factor: 4.307

Alport syndrome--clinical phenotypes, incidence, and pathology.

1. Ocular manifestations of Alport syndrome.

2. The effect of aldosterone blockade in patients with Alport syndrome.

3. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.

4. Persistent Isolated Hematuria in a Japanese Woman.

5. Alport syndrome: a rare cause of uraemia.

6. Self-Assembled Peptide-Based Biocomposites for Near-Infrared Light Triggered Drug Release to Tumor Cells.

7. Collagen IV in Normal Skin and in Pathological Processes.

Review 8. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.

9. Alport Syndrome: De Novo Mutation in the COL4A5 Gene Converting Glycine 1205 to Valine.

10. Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis.